Cargando…

Circadian behavior of mice deficient in PER1/PML or PER2/PML

BACKGROUND: Our recent studies demonstrate that the murine homolog of the human tumor suppressor promyelocytic leukemia (PML) regulates circadian behavior of mice. To further gather insight into PML’s contribution to circadian behavior, we generated two strains of mice deficient in one of the two pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miki, Takao, Chen-Goodspeed, Misty, Zhao, Zhaoyang, Lee, Cheng Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765970/ https://www.ncbi.nlm.nih.gov/pubmed/23984853 http://dx.doi.org/10.1186/1740-3391-11-9

Ejemplares similares

Interactive Organization of the Circadian Core Regulators PER2, BMAL1, CLOCK and PML
por: Miki, Takao, et al.
Publicado: (2016)

PML Degradation: Multiple Ways to Eliminate PML
por: Rabellino, Andrea, et al.
Publicado: (2013)

Regulation of NF-κB by PML and PML-RARα
por: Ahmed, Abrar, et al.
Publicado: (2017)

Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice
por: Wartman, Lukas D., et al.
Publicado: (2012)

PML and PML-like exonucleases restrict retrotransposons in jawed vertebrates
por: Mathavarajah, Sabateeshan, et al.
Publicado: (2023)

PML, SUMOylation, and Senescence
por: Ivanschitz, Lisa, et al.
Publicado: (2013)

PML goes to the centrosome
por: Wells, William A.
Publicado: (2005)

PML Bodies in Mitosis
por: Lång, Anna, et al.
Publicado: (2019)

PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation
por: Hands, Katherine J., et al.
Publicado: (2014)

Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
por: Bsteh, Gabriel, et al.
Publicado: (2017)

The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA
por: Jaffray, Ellis G., et al.
Publicado: (2023)

The DNA Binding Property of PML/RARA but Not the Integrity of PML Nuclear Bodies Is Indispensable for Leukemic Transformation
por: Liu, Xi, et al.
Publicado: (2014)

Japanese encephalitis virus perturbs PML-nuclear bodies by engaging in interactions with distinct porcine PML isoforms
por: Yang, Songbai, et al.
Publicado: (2023)

The role of PML ubiquitination in human malignancies
por: Chen, Ruey-Hwa, et al.
Publicado: (2012)

Differential Roles of PML Isoforms
por: Nisole, Sébastien, et al.
Publicado: (2013)

Is PML a Tumor Suppressor?
por: Mazza, Massimiliano, et al.
Publicado: (2013)

Immunosuppressive therapy in dermatology and PML
por: Sterry, Wolfram, et al.
Publicado: (2009)

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments
por: Bernard-Valnet, Raphael, et al.
Publicado: (2021)

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment
por: Himedan, Mai, et al.
Publicado: (2017)

Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as(2)O(3)-Induced Pml or Pml/Retinoic Acid Receptor α Degradation
por: Lallemand-Breitenbach, Valérie, et al.
Publicado: (2001)

Post-translational modifications of PML: consequences and implications
por: Cheng, Xiwen, et al.
Publicado: (2013)

PML: Not all about Tumor Suppression
por: Martin-Martin, Natalia, et al.
Publicado: (2013)

Emerging Cellular Functions of Cytoplasmic PML
por: Jin, Guoxiang, et al.
Publicado: (2013)

PML in the Brain: From Development to Degeneration
por: Korb, Erica, et al.
Publicado: (2013)

Treatment of natalizumab‐associated PML with filgrastim
por: Stefoski, Dusan, et al.
Publicado: (2019)

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
por: Han, Mingqi, et al.
Publicado: (2019)

Requirement of PML SUMO Interacting Motif for RNF4- or Arsenic Trioxide-Induced Degradation of Nuclear PML Isoforms
por: Maroui, Mohamed Ali, et al.
Publicado: (2012)

Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1
por: Ishov, Alexander M., et al.
Publicado: (1999)

The Herpesvirus Associated Ubiquitin Specific Protease, USP7, Is a Negative Regulator of PML Proteins and PML Nuclear Bodies
por: Sarkari, Feroz, et al.
Publicado: (2011)

A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics
por: Van Damme, Ellen, et al.
Publicado: (2010)

Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation
por: Wang, Qian Qian, et al.
Publicado: (2015)

Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo
por: Zhanfeng, Niu, et al.
Publicado: (2015)

Setting an immuno-TRAP for PML nuclear bodies
por: Short, Ben
Publicado: (2013)

PML Surfs into HIPPO Tumor Suppressor Pathway
por: Strano, Sabrina, et al.
Publicado: (2013)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Complete senescence: RB and PML share the task
por: Vernier, Mathieu, et al.
Publicado: (2014)

Restoring PML tumor suppression to combat cancer
por: Wolyniec, Kamil, et al.
Publicado: (2012)

The national incidence of PML in Sweden, 1988–2013
por: Iacobaeus, Ellen, et al.
Publicado: (2018)

Pembrolizumab as a treatment for PML?: Waiting for Godot
por: Du Pasquier, Renaud A.
Publicado: (2019)

Improving risk‐stratification of natalizumab‐associated PML
por: Tugemann, Bastian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_utu919almk4lh8nk1u86oi4ku3